Ben Haynor

Stock Analyst at Lake Street

(0.70)
# 3,764
Out of 4,749 analysts
38
Total ratings
30.77%
Success rate
-24.43%
Average return

Stocks Rated by Ben Haynor

Treace Medical Concepts
Dec 31, 2024
Initiates: Buy
Price Target: $15
Current: $10.05
Upside: +44.28%
Ekso Bionics Holdings
Oct 29, 2024
Maintains: Buy
Price Target: $2.5$2
Current: $0.54
Upside: +271.47%
Aspira Women's Health
Aug 14, 2024
Maintains: Buy
Price Target: $7$5.5
Current: $0.38
Upside: +1,358.50%
Myomo
Jul 9, 2024
Maintains: Buy
Price Target: $7$7.5
Current: $6.03
Upside: +24.38%
IceCure Medical
Mar 20, 2024
Maintains: Buy
Price Target: $1.9$2.9
Current: $1.25
Upside: +132.00%
Profound Medical
Mar 11, 2024
Maintains: Buy
Price Target: $13$11
Current: $6.45
Upside: +67.44%
Evogene
Oct 2, 2023
Initiates: Buy
Price Target: $19
Current: $1.57
Upside: +1,078.34%
Nano-X Imaging
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $7.28
Upside: +99.18%
NeuroOne Medical Technologies
Aug 15, 2023
Maintains: Buy
Price Target: $3.25$2.2
Current: $1.15
Upside: +91.30%
DarioHealth
Aug 11, 2023
Maintains: Buy
Price Target: $5.45$4.1
Current: $0.62
Upside: +561.29%
Maintains: Neutral
Price Target: $12$7
Current: $0.22
Upside: +3,155.81%
Maintains: Buy
Price Target: $10$5.55
Current: $2.40
Upside: +131.25%
Maintains: Buy
Price Target: $5.15$4.75
Current: $2.58
Upside: +84.11%
Maintains: Buy
Price Target: $15$7
Current: $8.24
Upside: -15.00%
Initiates: Buy
Price Target: $23
Current: $3.72
Upside: +511.56%
Maintains: Buy
Price Target: $15,950$13,485
Current: $3.77
Upside: +357,582.82%
Initiates: Buy
Price Target: $1,375
Current: $3.01
Upside: +45,581.06%